Back to Journals » OncoTargets and Therapy » Volume 13

RETRACTED ARTICLE: Circular RNA ZNF609 Promoted Hepatocellular Carcinoma Progression by Upregulating PAP2C Expression via Sponging miR-342-3p

Authors Liao X, Zhan W, Tian B, Luo Y, Gu F, Li R

Received 30 March 2020

Accepted for publication 6 July 2020

Published 4 August 2020 Volume 2020:13 Pages 7773—7783

DOI https://doi.org/10.2147/OTT.S253936

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. Takuya Aoki



This paper has been retracted.

Liao X, Zhan W, Tian B, Luo Y, Gu F, Li R. OncoTargets Ther. 2020;13:7773–7783.

The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised regarding the alleged duplication of images in Figure 5C with the same images in Figure 5C from Zhu et al, 2015 ‘bFGF-Regulating MAPKs Are Involved in High Glucose-Mediated ROS Production and Delay of Vascular Endothelial Cell Migration’ (https://doi.org/10.1371/journal.pone.0144495). Specifically,

  • Figure 5C, HepG2, 0h, si-NC+NC inh appears to have been duplicated with the same image from Figure 5C, 0 h, HG+sp from Zhu et al, 2015.
  • Figure 5C, HepG2, 0h, si-circZNF609+NC inh appears to have been duplicated with the same image from Figure 5C, 0 h, LG from Zhu et al, 2015.

The authors did not respond to our queries and no explanation for the alleged image duplication was provided. The Editor requested to retract the article and the authors were notified of this.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

Creative Commons License © 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.